Female's heightened immune status: estrogen, T cells, and inducible nitric oxide synthase in the balance.
Verthelyi
Daniela
D
Laboratory of Immunology, Division of Therapeutic Proteins, Center for Drug Evaluation and Review, Food and Drug Administration, Bethesda, Maryland 20892, USA. verthelyi@cber.fda.gov
D000222:Adaptation, Physiological / Q000276:immunology; D000818:Animals; D000938:Antigen-Presenting Cells / Q000276:immunology*; D004967:Estrogens / Q000276:immunology*; D005260:Female; D006801:Humans; D007113:Immunity, Innate / Q000502:physiology*; D008297:Male; D052247:Nitric Oxide Synthase Type II / Q000276:immunology*; D012737:Sex Factors; D013601:T-Lymphocytes / Q000276:immunology*
D004967:Estrogens; D052247:Nitric Oxide Synthase Type II